Immunity induced by DNA immunization with herpes simplex virus type 2 glycoproteins B and C

By Mester J.C.   Twomey T.A.   Tepe E.T.   Bernstein D.I.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 875-883

Elsevier

Access to resources Recommend Favorite

DNA immunization utilizing a herpes simplex virus type 2 myogenic DNA vaccine protects mice from mortality and prevents genital herpes

By Gebhard J.R.J.R.   Zhu J.   Cao X.   Minnick J.   Araneo A.B.A.  

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1837-1846

Elsevier

Access to resources Recommend Favorite

Protective immunity against herpes simplex virus generated by DNA vaccination compared to natural infection

By Nass P.H.   Elkins K.L.   Weir J.P.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1538-1546

Elsevier

Access to resources Recommend Favorite

Immunization with a LEAPS&unknown; heteroconjugate containing a CTL epitope and a peptide from beta-2-microglobulin elicits a protective and DTH response to herpes simplex virus type 1

By Rosenthal K.S.   Mao H.   Horne W.I.   Wright C.   Zimmerman D.  

Vaccine, Vol. 17, Iss. 6, 1999-02 ,pp. : 535-542

Elsevier

Access to resources Recommend Favorite

Intranasal immunization with recombinant gD2 reduces disease severity and mortality following genital challenge with herpes simplex virus type 2 in guinea pigs

By O'Hagan D.   Goldbeck C.   Ugozzoli M.   Ott G.   Burke R.L.  

Vaccine, Vol. 17, Iss. 18, 1999-05 ,pp. : 2229-2236

Elsevier

Access to resources Recommend Favorite